Announcement from Sansure Biotech Inc. Regarding the Profit Distribution Plan for the First Half of 2024.
Announcement on the progress of the actual controller and chairman of Sansure Biotech Inc. and their concerted action persons' shareholding, which is more than halfway through.
Announcement on the Results of the First Restricted Stock Incentive Plan for 2023 of Sansure Biotech Inc.
Announcement of Sansure Biotech Inc. regarding the proposal of the actual controller and director to distribute interim dividends, cancel some repurchased shares and implement the "Improving Quality and Efficiency to Achieve Returns" action plan for the company in 2024.
Announcement of Adjusting the Grant Price of Restricted Stock Incentive Plan for 2023 by Sansure Biotech Inc.
Announcement of Sansure Biotech Inc.'s Restrictive Stock Incentive Plan for the first vesting period in 2023 that meets the ownership conditions.
Legal Opinion of Qi Yuan Law Firm, regarding the adjustment of the grant price of restricted stock options and the achievement of the first vesting condition of Sansure Biotech Inc.'s 2023 Restricted Stock Incentive Plan.
Verification opinion of the first attribution list of the 2023 Restricted Stock Incentive Plan by the Supervisory Committee of Sansure Biotech Inc.
Announcement of the Implementation of Share Repurchase and Cancellation as well as Share Changes by Sansure Biotech Inc.
Announcement of Sansure Biotech Inc.'s 2023 annual equity distribution implementation.
Announcement of Shengxiang Biotechnology Co., Ltd. on the 2023 Profit Distribution Plan
Announcement of Shengxiang Biotechnology Co., Ltd. on the results of the 2021 Restricted Stock Incentive Plan granting part of the second vesting period for the first time and the first vesting period for the reservation grant
Announcement of Shengxiang Biotechnology Co., Ltd. on the 2021 Restricted Stock Incentive Plan for the first time granting part of the second vesting period and reserving the granting of part of the first vesting period to meet the conditions of ownership
Opinions of the Supervisory Board of Shengxiang Biotechnology Co., Ltd. on the 2021 Restricted Stock Incentive Plan for the first time granting a second vesting period and reserving the first vesting period for the 2021 Restricted Stock Incentive Plan
Announcement of Shengxiang Biotechnology Co., Ltd. on adjusting the price granted under the 2021 Restricted Stock Incentive Plan
Hunan Qiyuan Law Firm's 2021 Restricted Stock Incentive Plan grants a legal opinion on price adjustments, the first grant of part of the second vesting period, the achievement of the ownership conditions for the first time, and the cancellation of some res
Announcement of Shengxiang Biotechnology Co., Ltd. on the expiration of the shareholders' centralized bidding plan and the results of the share reduction
Announcement of Shengxiang Biotechnology Co., Ltd. on the plan of the actual controller and chairman and his co-actors to increase their shareholding
Legal opinion of Hunan Qiyuan Law Firm on matters relating to the grant of the second restricted stock incentive plan of Shengxiang Biotechnology Co., Ltd. in 2023
Verification opinions of the board of supervisors of Shengxiang Biotechnology Co., Ltd. on the list of incentive recipients granted for the first time in the second restricted stock incentive plan in 2023 (as of the grant date)
No Data